Exiqon A/S Launches LNA microRNA Target Site Blockers
6/27/2013 9:41:10 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of its miRCURY LNA™ microRNA Target Site Blocker products for efficient and specific blocking of microRNA binding.
Help employers find you! Check out all the jobs and post your resume.
comments powered by